X

Vous n'êtes pas connecté

  - MEDINDIA.NET - Medindia Health News - 14/Jul 17:27

Cracking the Cellular Code of Childhood Arthritis

First-of-its-kind study in children with arthritis uncovers unique joint cell architecture, revealing potential new targets for treatment.

Articles similaires

New research provides the first clinically relevant overview of childhood brain tumors

news.medical.net - 06:53

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't...

Why some rheumatoid arthritis patients don’t respond to treatment

knowridge.com - 26/Jul 15:14

Rheumatoid arthritis (RA) is usually treated with strong anti-inflammatory drugs that help reduce swelling and pain in the joints. But for about 20%...

Why some rheumatoid arthritis patients don’t respond to treatment

knowridge.com - 26/Jul 15:14

Rheumatoid arthritis (RA) is usually treated with strong anti-inflammatory drugs that help reduce swelling and pain in the joints. But for about 20%...

Sorry! Image not available at this time

Insulin Nasal Spray Reaches Alzheimer's Targets, Brain Scans Show

drugs.com - 24/Jul 09:07

THURSDAY, July 24, 2025 — Insulin delivered by nasal spray might be a potential treatment for Alzheimer’s disease, a new study says. An...

Chemotherapy might be making some cancers stronger, study warns

knowridge.com - 21/Jul 14:31

A new study from Houston Methodist reveals a surprising twist in the fight against bladder cancer: a type of cancer cell death triggered by...

Chemotherapy might be making some cancers stronger, study warns

knowridge.com - 21/Jul 14:31

A new study from Houston Methodist reveals a surprising twist in the fight against bladder cancer: a type of cancer cell death triggered by...

Sorry! Image not available at this time

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML (AB Science SA)

wn.com - 07:57

) PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE...

Sorry! Image not available at this time

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML (AB Science SA)

wn.com - 07:57

) PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE...

New Study Reveals DNA Code That Orchestrates Blood Cell Creation

medindia.net - 27/Jul 07:56

New study reveals how a DNA regulatory switch controls stem cell function, enabling the production of blood cells and offering insights for future...

Research reveals financial toll of living with type 2 diabetes

news.medical.net - 28/Jul 18:58

In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes...